OCC 1.32% 38.5¢ orthocell limited

I think they call it total apathy. Investors are fed upwith...

  1. 1,602 Posts.
    lightbulb Created with Sketch. 167
    I think they call it total apathy. Investors are fed up
    with pushed back timelines, glacial progress
    toward regulatory approval and a decent revenue
    stream.

    I sure do regret selling out of mining and energy
    to buy into biotech. Biggest mistake of my life in
    investment terms.

 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.